By Stephen Nakrosis
Shares of Nutex Health climbed following fourth-quarter results that topped analysts' estimates, including a significant increase in revenue.
Fourth-quarter revenue more than tripled to $257.6 million from $69.7 million a year ago. Analysts were expecting revenue of $81.1 million.
The healthcare-management and operations company said it believes its arbitration efforts, through the independent dispute resolution process, resulted in more equitable payments.
The stock was up 41%, to $66.51 a share, in after-hours trading Monday, after closing the regular session down 9%, at $47.03. Shares at one point reached $72.00 apiece in post-market trading, topping the 52-week high of $69.45 set on Feb. 14.
The Houston company reported net income for the fourth quarter of $61.7 million, and earnings per share of $11.12, compared with a loss of $31.6 million, for a loss of $7.47 per share, in the same period a year earlier.
Analysts expected a fourth-quarter loss of $600,000, or 12 cents a share, according to a survey by FactSet.
Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
March 31, 2025 19:23 ET (23:23 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。